These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3893841)
1. Clinical pharmacokinetics of bretylium. Rapeport WG Clin Pharmacokinet; 1985; 10(3):248-56. PubMed ID: 3893841 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of bretylium in man after intravenous administration. Narang PK; Adir J; Josselson J; Yacobi A; Sadler J J Pharmacokinet Biopharm; 1980 Aug; 8(4):363-72. PubMed ID: 7431227 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: clinical application of a new assay for bretylium. Anderson JL; Patterson E; Wagner JG; Johnson TA; Lucchesi BR; Pitt B J Cardiovasc Pharmacol; 1981; 3(3):485-99. PubMed ID: 6168830 [TBL] [Abstract][Full Text] [Related]
6. Bretylium tosylate: profile of the only available class III antiarrhythmic agent. Anderson JL Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143 [TBL] [Abstract][Full Text] [Related]
7. Bretylium pharmacokinetics and bioavailabilities in man with various doses and modes of administration. Garrett ER; Green JR; Bialer M Biopharm Drug Dispos; 1982; 3(2):129-64. PubMed ID: 7104462 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of bretylium in dogs and the effect of hemoperfusion on elimination. Kamath BL; Gibson TP; Look ZM; McEntegart CM; Comrie EB; Yacobi A J Pharm Sci; 1982 Nov; 71(11):1294-6. PubMed ID: 7175729 [TBL] [Abstract][Full Text] [Related]